Andrew R. Morton
Neuroscience · Indiana University
Publications
68
Citations
2,119
Est. group size
—
Recurring co-author estimate
Active years
35
Publishing since 1992
Andrew R. Morton studies how the way DNA is packaged and regulated inside cells shapes the behavior of brain tumors and other cancers. Much of the work maps the 'switches' (chromatin and enhancer landscapes) that control gene activity in cancers such as glioblastoma and meningioma, including how disrupting the body's internal clock (circadian rhythm) might be used to target tumor stem cells. The goal is to identify new biological weak points that could be targeted with drugs.
Publication activity has been variable, with a large spike in 2023 (including many supplementary data records) followed by fewer outputs, averaging about 4.4 per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Typically publishes in teams of ~20 · 7% small-team papers (≤3 authors) · across 15 venues
- Late Time Weak Field Scaling Consistency Test for the Hubble and S8 Cosmological Tensions
Research Square · 2026
- Transient gene melting governs the timing of oligodendrocyte maturation
Cell · 2025
- Interlocking host and viral cis-regulatory networks drive Merkel cell carcinoma
Journal of Clinical Investigation · 2025
- Correction: Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma
The Journal of Experimental Medicine · 2025
- Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting
JCI Insight · 2023
- Supplementary reagents from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
2023
- Supplementary methods from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
2023
- Supplementary table S1 from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
2023
- Supplementary figures and legends from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
2023
- Supplementary reagents from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
2023
- Data from The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies
2023
- Data from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
2023
- Supplementary Data 1 from The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies
2023
- Supplementary Information from The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies
2023
- Supplementary Data 1 from The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies
2023
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Cell×2
- Cell stem cell×2
- Cancer Discovery×2
- Nature×2
- Swathi Yadlapalli
Neuroscience · University of Michigan
- Chia Chun Hor
Neuroscience · University of Michigan
- Aishwarya Ramakrishnan
Neuroscience · Indiana University
- Ahmet B. Çağlayan
Neuroscience · University of Michigan
- Caleb Mayer
Neuroscience · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 27, 2026.
Claim or correct this profile